Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
Stanford Legal
Also in News Commentary
Government
FDA Watch
by FDA Watch
Today: #193 in Government, United Kingdom on our combined chart.
Today: #181 in Government, Japan on our combined chart.
Chart positions today · United States
Not on the United States charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like FDA Watch, try…
Q-POINT
Also in News Commentary
Overheard at the Bush Center
Also in News Commentary
The John Phillips Show
Also in News Commentary
Ray Appleton
Also in News Commentary
America, Actually with Astead Herndon
Also in News Commentary
Ranking history · United States
Latest daily rankings: Oct 27. New rankings will appear after the next update.
Recent history only — this show has no current ranking on the Government chart. These are recorded positions from the last 14 days, not current rankings.
Position on the Government combined chart over the last 14 days. Toggle platforms to compare their positions. Lower rank numbers are better.
Episode releases
View as table
| Date | Combined Rank | Apple Podcasts | Castbox |
|---|---|---|---|
| Oct 27 | — | — | — |
| Oct 26 | #163 | #165 | — |
| Oct 25 | #111 | #115 | #98 |
| Oct 24 | #149 | #150 | — |
| Oct 23 | #132 | #131 | — |
| Oct 22 | #76 | #76 | #75 |
| Oct 21 | #83 | #83 | #83 |
| Oct 20 | #159 | #160 | — |
| Oct 19 | #92 | #94 | #90 |
| Oct 16 | #181 | #183 | — |
| Oct 15 | #107 | #108 | #95 |
| Oct 14 | #146 | #146 | — |
Latest episodes
-
What's Ahead for FDA and MedTech
October 26, 2026 · 50 minWayne chats with Philip Desjardins, Partner at Arnold & Porter; Sean Boyd, Corporate Vice President at QualityHub; and Rusty Segan, CEO of Medical Scientific Advisors. You'll hear their takeaways from AdvaMed's MedTech Conference and…
-
FDA Legal, Regulatory & Compliance Issues, Part 4: Mergers & Acquisitions
October 22, 2026 · 43 minIn this fourth and final part of our series in collaboration with Arnall Golden Gregory LLP, Wayne chats with Alan Minsk, Partner, Chair of the Food & Drug practice, and Co-chair of the Life Sciences industry team at AGG; and Brian Teras…
-
The Rise of Real-World Evidence in Regulatory Strategy, Part 3: RWE in Accelerated Approvals
October 19, 2026 · 43 minIn this third part of our series in collaboration with Analysis Group, Wayne chats with Dr. Maral DerSarkissian, Managing Principal at Analysis Group; Dr. Mark Robbins, President and CEO of Kodiak Strategic Consultants; and Bethany Hills…
-
The Rise of Real-World Evidence in Regulatory Strategy, Part 2: RWE in Medical Devices
October 15, 2026 · 44 minIn this second part of our new series in collaboration with Analysis Group, Wayne chats with Dr. Mary Beth Ritchey, Principal of Med Tech Epi LLC, and Associate Research Professor at Rutgers University; and Cori Maegley, Vice President of…
-
An Evolving Direction for Drug Oversight
October 12, 2026 · 34 minWayne chats with Brian Malkin, Partner at Spencer Fane. You'll hear Brian's thoughts on potential FDA leadership under Heidi Overton, early priorities for drug and biologics companies, implications for drug pricing, AI in drug development…
Show 7 more episodesShow fewer episodes
-
The Rise of Real-World Evidence in Regulatory Strategy, Part 1: RWE in Rare Disease Drug Development
September 21, 2026 · 46 minIn this first part of our new series in collaboration with Analysis Group, Wayne chats with Dr. James Signorovitch, Managing Principal at Analysis Group; Bethany Hills, Regulatory Partner at White & Case; and Dr. Dilesh Doshi, Vice…
-
What's Actually Happening in Cosmetics & Personal Care
September 14, 2026 · 46 minWayne chats with Meredith Petillo, Vice President of Technical and Regulatory Affairs at the Independent Beauty Association, and Claire Bing, CEO and Founder of Confiance Cosmetic Group. You'll hear their thoughts on recent activity in the…
-
Food Safety in the Spotlight
September 8, 2026 · 50 minWayne chats with Mason Weeda, Managing Principal at OFW Law and Chair of the firm's FDA Food Practice, and Jessica O'Connell, Partner at Covington and Co-Chair of the firm's Food, Drug, and Device Practice Group. You'll hear their thoughts…
-
FDA Legal, Regulatory & Compliance Issues, Part 3: Advertising & Promotion
August 17, 2026 · 46 minIn this third part of our series in collaboration with Arnall Golden Gregory LLP, Wayne chats with Alan Minsk, Partner, Chair of the Food & Drug practice, and Co-chair of the Life Sciences industry team at AGG; and Laura LaBrie, Associate…
-
Keeping Up with Medical Device Manufacturing and Digital Health
August 10, 2026 · 48 minWayne chats with Cathy Burgess, Partner and Head of the FDA Compliance and Enforcement Team and FDA Practice at Alston & Bird, and Michael Gaba, Food and Drug Vice Chair at Polsinelli. You'll hear their thoughts on what's happening these…
-
An Extensive Breakdown of the Pharmaceutical and Biologics Landscape
August 3, 2026 · 48 minWayne chats with Daniel Kracov, Partner and Chair of the Life Sciences Industry Group at Arnold & Porter, and Dr. Gayatri Rao, Director at Hyman, Phelps & McNamara. You'll hear their thoughts on Operation TrialBlazer; what's been happening…
-
FDA Legal, Regulatory & Compliance Issues, Part 2: Customs Regulation & International Trade
July 27, 2026 · 40 minIn this second part of our series in collaboration with Arnall Golden Gregory LLP, Wayne chats with Luis Arandia Jr., Partner and Co-chair of International Trade at AGG, and Allison Raley, Partner in AGG's Corporate & Finance practice and…
About the show
FDA Watch is a twice-monthly, national podcast that provides an independent, non-partisan forum for discussing and understanding the latest developments, trends, and issues involving FDA. The podcast focuses on four core areas: pharmaceuticals and biologics; medical devices and diagnostics; food and dietary supplements; and cosmetics and personal care products, as well as on the overall direction of FDA regulation. The podcast also will have bonus episodes to cover breaking news. Podcast guests analyze FDA regulations, guidances, and policy developments and engage in insightful and revealing conversations with host Wayne Pines, former FDA associate commissioner and author/editor of 16 books about FDA. Subscribers to the podcast include regulatory affairs specialists, food and drug attorneys, policymakers, government officials, strategic planners, and IT and cybersecurity professionals.